Month: August 2015

Recon takes an analytical look behind select developments in healthcare

So what if PCPs in ACO practices are not paid differently?

Diana Poon August 3, 2015

In a recent study, Ryan, Shortell, et al analyzed the composition of PCP compensation (broken down into salary, productivity and quality/other components) across practices with ACO contracts vs. those with more traditional business models. This note will: provide a quick summary of results offer an alternative interpretation of the data describe two methodological points regarding the data set The major finding As of 2012/2013, there are no major systematic differences in how PCPS are paid in ACO practices vs. others. Whether in an ACO or not, PCPs were paid on

NEJM Highlights July 2015: a first in class drug for cancer, Sovaldi cures renal failure too (sometimes), convenient primary care

Marc Herant August 2, 2015

Palbociclib – first to target cyclin dependent kinases – breast cancer As all biology majors know, cyclin dependent kinases are critical elements controlling the machinery of cell proliferation. They have proved difficult targets due to their ubiquitous activity in both normal and abnormal tissue – until now. In a phase 3 study, about 500 patients with metastatic hormone positive, Her2 negative breast cancer were treated with palbociclib (Ibrance, Pfizer, recently FDA approved) vs. placebo. The median disease progression time for patients on drug was 5 months longer than for placebo

Month: August 2015

Recon takes an analytical look behind select developments in healthcare

So what if PCPs in ACO practices are not paid differently?

NEJM Highlights July 2015: a first in class drug for cancer, Sovaldi cures renal failure too (sometimes), convenient primary care

SUBSCRIBE

Categories

Authors

Archives